266 related articles for article (PubMed ID: 19602036)
1. Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor.
Hwang CK; Song KY; Kim CS; Choi HS; Guo XH; Law PY; Wei LN; Loh HH
J Cell Mol Med; 2009 Sep; 13(9B):3591-615. PubMed ID: 19602036
[TBL] [Abstract][Full Text] [Related]
2. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters.
Hwang CK; Song KY; Kim CS; Choi HS; Guo XH; Law PY; Wei LN; Loh HH
Mol Cell Biol; 2007 Jul; 27(13):4720-36. PubMed ID: 17452465
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells.
Hwang CK; Kim CS; Kim DK; Law PY; Wei LN; Loh HH
Mol Pharmacol; 2010 Jul; 78(1):58-68. PubMed ID: 20385708
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Activation of
Wagley Y; Law PY; Wei LN; Loh HH
Mol Pharmacol; 2017 Apr; 91(4):357-372. PubMed ID: 28153853
[TBL] [Abstract][Full Text] [Related]
6. Chronic high-fat diet drives postnatal epigenetic regulation of μ-opioid receptor in the brain.
Vucetic Z; Kimmel J; Reyes TM
Neuropsychopharmacology; 2011 May; 36(6):1199-206. PubMed ID: 21326195
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.
Cao Y; Vo T; Millien G; Tagne JB; Kotton D; Mason RJ; Williams MC; Ramirez MI
J Biol Chem; 2010 Jan; 285(3):2152-64. PubMed ID: 19906647
[TBL] [Abstract][Full Text] [Related]
9. Brain region-specific expression of Fxyd1, an Mecp2 target gene, is regulated by epigenetic mechanisms.
Banine F; Matagne V; Sherman LS; Ojeda SR
J Neurosci Res; 2011 Jun; 89(6):840-51. PubMed ID: 21394759
[TBL] [Abstract][Full Text] [Related]
10. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
[TBL] [Abstract][Full Text] [Related]
11. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
12. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
13. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
Elife; 2019 Dec; 8():. PubMed ID: 31868585
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter.
Sharma D; Bhave S; Gregg E; Uht R
Mol Endocrinol; 2013 Jul; 27(7):1142-52. PubMed ID: 23671328
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
[TBL] [Abstract][Full Text] [Related]
16. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.
Skene PJ; Illingworth RS; Webb S; Kerr AR; James KD; Turner DJ; Andrews R; Bird AP
Mol Cell; 2010 Feb; 37(4):457-68. PubMed ID: 20188665
[TBL] [Abstract][Full Text] [Related]
17. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
18. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
Hansen JC; Ghosh RP; Woodcock CL
IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
[TBL] [Abstract][Full Text] [Related]
19. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
20. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain.
Kernohan KD; Jiang Y; Tremblay DC; Bonvissuto AC; Eubanks JH; Mann MR; Bérubé NG
Dev Cell; 2010 Feb; 18(2):191-202. PubMed ID: 20159591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
